Agrimony (Agrimonia eupatoria)

Agrimonia eupatoria
Evidence Level
Limited
4 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Agrimony (Agrimonia eupatoria) is a European meadow herb in the rose family whose dried flowering tops are brewed as a tea or made into tinctures and liquid extracts. It is rich in tannins, mainly proanthocyanidins with some ellagitannins such as agrimoniin, plus flavonoids such as isoquercitrin and rutin. The European Medicines Agency lists it only as a traditional herbal medicine, based on long-standing use rather than clinical trials. Human research on oral use is small: one placebo-controlled trial of a water extract in 80 Korean adults with raised liver enzymes, and one study without a control group in which 19 healthy Bulgarian adults drank agrimony tea for a month. Most other findings come from cell, tissue and animal work. It is not recommended during pregnancy or breastfeeding, or for children under 12.

Studied Dose Two 200 ml cups of tea a day for 30 days in the tea study; capsules of a water extract, two twice daily for 8 weeks, in the liver-enzyme trial (amount per capsule not given in the abstract). EU traditional tea: 1.5 to 4 g herb per cup, 2 to 3 times daily.
Active Compound Tannins (at least 2% in the European Pharmacopoeia herb; mainly proanthocyanidins, plus ellagitannins such as agrimoniin) and flavonoids, mainly hyperoside with rutin and isoquercitrin.

Benefits

Liver enzymes and triglycerides in adults with raised ALT

In an 8-week placebo-controlled trial in Korea, 80 adults with mildly to moderately raised ALT (45 to 135 IU/L) took capsules of a water extract twice daily; 69 were analyzed. ALT and triglycerides fell more than with placebo (P = 0.044 and 0.020), while ALP, bilirubin and GGT did not differ. Three co-authors listed company affiliations.

Blood antioxidant capacity in healthy adults

In 19 healthy adults aged 20 to 55 who drank two 200 ml cups of agrimony tea a day for 30 days, serum total antioxidant capacity rose significantly. A second antioxidant test (FRAP) did not change significantly, and serum thiol levels fell. There was no control group, so the changes cannot be separated from other influences over the month.

HDL cholesterol in healthy adults

In the same 30-day tea study, HDL cholesterol rose and tracked with the hormone adiponectin. The lead author's dissertation summary adds that total cholesterol also rose, LDL cholesterol did not change, all lipids stayed within reference ranges, and adiponectin itself did not change significantly. This is one small study without a control group.

Inflammation marker IL-6 in healthy adults

Serum interleukin 6 (IL-6) fell significantly after 30 days of agrimony tea in the 19-person study, while C-reactive protein (CRP) did not change and stayed in the normal range. With no control group and only one of two inflammation markers moving, this does not show a lasting anti-inflammatory effect.

Blood sugar handling in lab and animal studies

In mice with chemically induced diabetes, agrimony mixed into food and drinking water countered high blood sugar, weight loss and excess thirst. A hot-water extract raised glucose uptake in mouse muscle and insulin release from cultured pancreatic cells. These are animal and cell findings, not results in people.

Artery relaxation in lab-tested human vessel tissue

In segments of chest-wall artery collected during heart bypass surgery, an agrimony infusion relaxed pre-contracted vessels strongly (maximum above 76%), partly through nitric oxide and cyclooxygenase pathways, with isoquercitrin a likely contributor. At a low concentration it also strengthened contraction. Tissue-bath work, not a blood pressure study.

Mechanism of action

1

Tannin-rich astringent herb

Agrimony's characteristic compounds are tannins, mainly condensed proanthocyanidins with a smaller share of ellagitannins. European regulators consider them likely contributors to its traditional effects, but no constituent with proven therapeutic activity has been identified, and no studies confirm in people which compounds are responsible.

2

Polyphenol antioxidant and anti-inflammatory activity in the lab

Agrimony infusion and its polyphenol fraction neutralized several free radicals in test-tube assays, lowered nitric oxide release from stimulated immune cells, and reduced paw swelling and pain responses in rodents at doses without signs of toxicity. These are laboratory and animal findings.

3

Insulin release and glucose uptake in cells

A hot-water extract stimulated insulin release from a pancreatic cell line in a dose-dependent way (1.9 to 3.8-fold), an effect blocked by diazoxide and dependent on heat during extraction, and raised glucose transport and glycogen formation in mouse muscle. Whether tea drinking has these effects in people is unknown.

Clinical trials

1
Agrimony Water Extract in Adults with Raised ALT: 8-Week Placebo-Controlled RCT
PubMed

Randomized, double-blind, placebo-controlled trial run from January to July 2013 at a Korean oriental medicine hospital; capsules of an aqueous agrimony extract, two capsules twice daily. Three co-authors listed affiliations with two Korean companies. (Cho et al. 2018, J Med Food)

80 adults aged 20 or older with mildly to moderately raised ALT (45 to 135 IU/L); 69 analyzed (34 extract, 35 placebo) after 11 were excluded for protocol violation or withdrawn consent.

After 8 weeks, ALT (P = 0.044) and serum triglycerides (P = 0.020) fell more with the extract than with placebo, with significant group by time interactions for ALT, AST and triglycerides. ALP, total bilirubin and GGT did not differ between groups. No severe adverse events were reported. The abstract does not state the amount of extract per capsule, and the effect on liver health beyond these lab values was not measured.

2
Agrimony Tea for 30 Days in 19 Healthy Adults (no control group)
PubMed

Single-group before-and-after intervention study; 200 ml of agrimony tea at 9 am and 2 pm daily for 30 days, with fasting blood drawn on day 1 and day 30. Supported by a national research fund, COST Action BM0602 and a Medical University of Varna research fund. (Ivanova et al. 2013, Arch Physiol Biochem)

19 healthy volunteers aged 20 to 55 in Varna, Bulgaria (5 women, 14 men), asked not to change their diet or lifestyle (details from the lead author's dissertation summary).

Serum total antioxidant capacity rose (P < 0.001) and IL-6 fell, and HDL cholesterol rose and correlated with adiponectin. Per the dissertation summary, FRAP and adiponectin did not change significantly, CRP and LDL cholesterol were unchanged, total cholesterol rose, and serum thiols fell. Without a control group, these changes cannot be attributed to the tea with confidence.

3
Four-Herb Formula Including Agrimony in IBS: Open-Label Pilot (no control group)
PubMed

Two-arm, open-label, uncontrolled pilot study in Australia (recruited 2001). The agrimony-containing formula combined dried powdered bilberry fruit, slippery elm bark, agrimony aerial parts and cinnamon. (Hawrelak et al. 2010, J Altern Complement Med)

31 people meeting Rome II criteria for irritable bowel syndrome; the 21 with diarrhea-predominant or alternating bowel habit took the agrimony-containing formula (the other 10 took a different formula without agrimony).

The authors concluded the agrimony-containing formula did not improve bowel habit, although bowel movement frequency rose slightly (P = 0.027) and straining, abdominal pain, bloating, flatulence and global symptom scores fell during treatment. With four herbs, no placebo and no control group, agrimony's own contribution cannot be judged.

4
Agrimony Infusion on Human Artery Segments: Lab Tissue Study
PubMed

Organ-bath study of an agrimony infusion, an ethyl acetate fraction and isolated constituents on human internal thoracic artery tissue, with blockers of the nitric oxide and cyclooxygenase pathways. (Malheiros et al. 2022, Pharmaceuticals (Basel))

Distal artery segments harvested from patients undergoing coronary revascularization surgery in Coimbra, Portugal; no one took agrimony by mouth.

The infusion caused strong concentration-dependent relaxation (maximum above 76%), reduced by blocking nitric oxide synthase and cyclooxygenase, but at 0.02 mg/ml it also raised basal tone slightly and boosted noradrenaline-induced contraction by 49%. Isoquercitrin reproduced much of the fraction's activity. Effects in a tissue bath do not show what drinking the tea does to blood vessels or blood pressure.

Side effects and drug interactions

Common Potential side effects

The EU herbal monograph lists no known undesirable effects, and its assessment found no adverse events reported in the literature or by EU member states; however, human safety data are very limited.
In the 8-week extract trial no severe adverse events were reported.
Not recommended during pregnancy or breastfeeding, or for children under 12, because safety has not been established.
Genotoxicity testing is incomplete: older bacterial (Ames) tests were negative, and a lab study of a methanol extract found no mutations or chromosome damage but did see increased DNA strand damage in the comet assay in human white blood cells. Reproductive toxicity and cancer studies have not been done.
Tinctures and liquid extracts contain alcohol (25 to 45% ethanol in the EU monograph preparations).
The EU monograph advises seeing a doctor if bowel symptoms last more than 3 days, recur, worsen, or include bloody stools.

Important Drug interactions

No interactions are reported in the European Medicines Agency assessment.
Diabetes medicines: mouse and cell studies suggest agrimony may lower blood sugar. No interaction cases have been reported, but people taking glucose-lowering medicines should check with their clinician before regular use.
Alcohol-containing tinctures may matter for people who must avoid alcohol or take medicines that should not be combined with it.

Frequently asked questions about Agrimony (Agrimonia eupatoria)

How is agrimony usually taken?

As a tea made from the dried flowering tops. The EU traditional-use monograph gives 1.5 to 4 g of herb in up to 250 ml of boiling water, 2 to 3 times daily, or 1 to 4 ml of tincture or 1 to 3 ml of liquid extract three times daily, for adolescents and adults. These amounts rest on long-standing use, not on trials. The tea study used two 200 ml cups a day for a month. Gargle preparations are for the mouth and are not meant to be swallowed as a supplement.

What does human research on agrimony show?

Very little so far. One placebo-controlled trial in 80 Korean adults with raised liver enzymes found a water extract lowered ALT and triglycerides over 8 weeks, but three co-authors had company ties and other liver markers did not change. A month-long tea study in 19 healthy adults without a control group saw higher antioxidant capacity and HDL cholesterol and lower IL-6. Neither has been repeated.

Is agrimony safe to drink?

European regulators list no known side effects or drug interactions for traditional use, and the extract trial reported no severe adverse events, but formal safety testing is incomplete. It is not recommended during pregnancy or breastfeeding, or for children under 12. People taking glucose-lowering medicines should check with a clinician, since animal studies hint at a blood sugar effect.

Is agrimony the same as hairyvein agrimony (Agrimonia pilosa)?

No. Agrimonia pilosa is a related Asian species with its own research, including a 2025 Japanese trial of a maker-funded extract that did not meet its primary immune-cell endpoint. Findings for one species should not be assumed to apply to the other, so check which plant a product contains.

What is Agrimony?

Agrimony (Agrimonia eupatoria) is a European meadow herb in the rose family whose dried flowering tops are brewed as a tea or made into tinctures and liquid extracts. It is rich in tannins, mainly proanthocyanidins with some ellagitannins such as agrimoniin, plus flavonoids such as isoquercitrin and rutin.

What is Agrimony used for?

Agrimony is researched primarily for Liver Health. In an 8-week placebo-controlled trial in Korea, 80 adults with mildly to moderately raised ALT (45 to 135 IU/L) took capsules of a water extract twice daily; 69 were analyzed. ALT and triglycerides fell more than with placebo (P = 0.

What is the recommended dosage of Agrimony?

The clinically studied dose is Two 200 ml cups of tea a day for 30 days in the tea study; capsules of a water extract, two twice daily for 8 weeks, in the liver-enzyme trial (amount per capsule not given in the abstract). EU traditional tea: 1.5 to 4 g herb per cup, 2 to 3 times daily. Always follow the product label and check with a healthcare provider for personal advice.

Is Agrimony safe, and does it have side effects?

Side effects and cautions reported for Agrimony include: The EU herbal monograph lists no known undesirable effects, and its assessment found no adverse events reported in the literature or by EU member states; however, human safety data are very limited. In the 8-week extract trial no severe adverse events were reported. It may also interact with some medications. Agrimony is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Agrimony interact with any medications?

Possible interactions include: No interactions are reported in the European Medicines Agency assessment. Diabetes medicines: mouse and cell studies suggest agrimony may lower blood sugar. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Agrimony?

NutraSmarts rates the evidence for Agrimony as Limited (2 out of 5). It is backed by 4 clinical trials and 12 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(12 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Cho YM, Kwon JE, Lee M, Lea Y, Jeon DY, Kim HJ, Kang SC. Agrimonia eupatoria L. (Agrimony) Extract Alters Liver Health in Subjects with Elevated Alanine Transaminase Levels: A Controlled, Randomized, and Double-Blind Trial. J Med Food. 2018;21(3):282-288. doi: 10.1089/jmf.2017.4054.PubMedUsed to support: Randomized, double-blind, placebo-controlled 8-week trial in 80 Korean adults with ALT of 45 to 135 IU/L (69 analyzed): an aqueous agrimony extract (two capsules twice daily) lowered ALT and triglycerides more than placebo (P = 0.044 and 0.020); ALP, bilirubin and GGT did not differ; no severe adverse events. Three co-authors listed company affiliations; the abstract gives no mg dose.
  2. Ivanova D, Vankova D, Nashar M. Agrimonia eupatoria tea consumption in relation to markers of inflammation, oxidative status and lipid metabolism in healthy subjects. Arch Physiol Biochem. 2013;119(1):32-7. doi: 10.3109/13813455.2012.729844.PubMedUsed to support: One month of agrimony tea in healthy volunteers, described by the authors as the first human intervention study with the tea: plasma total antioxidant capacity rose, interleukin 6 fell, and HDL cholesterol rose and correlated with adiponectin. The abstract reports no control group.
  3. Ivanova D. Dissertation summary (avtoreferat) on the antioxidant and metabolic effects of Bulgarian medicinal plants, including a human agrimony tea study (in Bulgarian). Medical University of Varna. 2013;Dissertation summary, Medical University of Varna library, 2013 (not PubMed-indexed)..SourceUsed to support: Not PubMed-indexed. The lead author's dissertation summary gives the tea study's design: 19 healthy volunteers aged 20 to 55 (5 women, 14 men) drank 200 ml of agrimony tea at 9 am and 2 pm for 30 days. Serum total antioxidant capacity rose (P < 0.001), FRAP did not change significantly, IL-6 fell, CRP was unchanged, HDL and total cholesterol rose, LDL was unchanged, adiponectin did not change significantly, and serum thiols fell.
  4. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Agrimonia eupatoria L., herba. Final. EMA/HMPC/680597/2013. European Medicines Agency. 2015;Adopted 28 January 2015 (not PubMed-indexed)..SourceUsed to support: Not PubMed-indexed. Traditional-use monograph based exclusively on long-standing use: oral herbal tea (1.5 to 4 g in up to 250 ml boiling water, 2 to 3 times daily), tincture 1 to 4 ml or liquid extract 1 to 3 ml three times daily for mild diarrhea, plus gargle and skin uses. Not recommended under 12 years or in pregnancy and lactation; no known undesirable effects or interactions; genotoxicity, carcinogenicity and reproductive toxicity tests not performed.
  5. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment report on Agrimonia eupatoria L., herba. Final. EMA/HMPC/680595/2013. European Medicines Agency. 2015;Adopted 28 January 2015 (not PubMed-indexed)..SourceUsed to support: Not PubMed-indexed. Finds clinical data very limited (one small uncontrolled study located), so agrimony does not qualify as well-established use; tannins (3 to 11%, mainly proanthocyanidins with some ellagitannins) are considered likely contributors, but no constituent with known therapeutic activity was identified. No adverse events reported; Ames tests negative but genotoxicity data insufficient; mouse data hint at blood sugar lowering, with no interaction cases.
  6. Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med. 2010;16(10):1065-71. doi: 10.1089/acm.2009.0090.PubMedUsed to support: Open-label, uncontrolled pilot in 31 people with IBS: 21 with diarrhea-predominant or alternating IBS took a powder of bilberry, slippery elm, agrimony and cinnamon. The authors concluded it did not improve bowel habit, though several symptom scores fell. Agrimony's own effect cannot be isolated.
  7. Gray AM, Flatt PR. Actions of the traditional anti-diabetic plant, Agrimony eupatoria (agrimony): effects on hyperglycaemia, cellular glucose metabolism and insulin secretion. Br J Nutr. 1998;80(1):109-14. doi: 10.1017/s0007114598001834.PubMedUsed to support: Animal and cell study: agrimony in the diet (62.5 g/kg) and drinking water (2.5 g/l) countered weight loss, excess thirst and eating, and high blood sugar in streptozotocin-diabetic mice; an aqueous extract raised glucose uptake and glycogen formation in mouse muscle and stimulated insulin secretion 1.9 to 3.8-fold in a pancreatic cell line. No human data.
  8. Santos TN, Costa G, Ferreira JP, Liberal J, Francisco V, Paranhos A, Cruz MT, Castelo-Branco M, Figueiredo IV, Batista MT. Antioxidant, Anti-Inflammatory, and Analgesic Activities of Agrimonia eupatoria L. Infusion. Evid Based Complement Alternat Med. 2017;2017:8309894. doi: 10.1155/2017/8309894.PubMedUsed to support: Lab and rodent study: agrimony infusion and its polyphenol fraction scavenged several free radicals, lowered nitric oxide from stimulated macrophages, and showed anti-inflammatory and pain-reducing activity in rodent models at concentrations without signs of toxicity. No human data.
  9. Malheiros J, Simões DM, Antunes PE, Figueirinha A, Cotrim MD, Fonseca DA. Vascular Effects of Polyphenols from Agrimonia eupatoria L. and Role of Isoquercitrin in Its Vasorelaxant Potential in Human Arteries. Pharmaceuticals (Basel). 2022;15(5):638. doi: 10.3390/ph15050638.PubMedUsed to support: Organ-bath study on human internal thoracic artery segments from bypass surgery patients: agrimony infusion caused strong vasorelaxation (maximum above 76%) involving nitric oxide and cyclooxygenase pathways, but at 0.02 mg/ml also raised basal tone and boosted adrenergic contraction by 49%. Isoquercitrin appeared to be a major active compound. Tissue study, not oral use.
  10. Pukalskienė M, Slapšytė G, Dedonytė V, Lazutka JR, Mierauskienė J, Venskutonis PR. Genotoxicity and antioxidant activity of five Agrimonia and Filipendula species plant extracts evaluated by comet and micronucleus assays in human lymphocytes and Ames Salmonella/microsome test. Food Chem Toxicol. 2018;113:303-313. doi: 10.1016/j.fct.2017.12.031.PubMedUsed to support: In vitro study of methanolic extracts of five Agrimonia and Filipendula species, including A. eupatoria: strong antioxidant activity; extracts increased DNA damage in the comet assay in human lymphocytes but caused no reverse mutations in the Ames test and were not genotoxic in the micronucleus test, with a slight drop in the nuclear division index.
  11. Malheiros J, Simões DM, Figueirinha A, Cotrim MD, Fonseca DA. Agrimonia eupatoria L.: An integrative perspective on ethnomedicinal use, phenolic composition and pharmacological activity. J Ethnopharmacol. 2022;296:115498. doi: 10.1016/j.jep.2022.115498.PubMedUsed to support: Review: agrimony is rich in phenolic acids, flavonoids and tannins (commonly astragalin, cynaroside, hyperoside, isoquercitrin, isovitexin, rutin, catechin, procyanidin B3 and agrimoniin); extracts show antioxidant, antimicrobial, antidiabetic, antinociceptive and anti-inflammatory activity in experiments, and the authors note pharmacological evidence for the traditional uses is still limited.
  12. Shimizu Y, Shimodan S, Hayashida M, Yazaki M, Sakurada T, Watanabe T, Ishii Y, Hirose Y, Saito J, Teramoto S. Preliminary Data on the Senolytic Effects of Agrimonia pilosa Ledeb. Extract Containing Agrimols for Immunosenescence in Middle-Aged Humans: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Study. Nutrients. 2025;17(4):667. doi: 10.3390/nu17040667.PubMedUsed to support: Concerns a different species, Asian Agrimonia pilosa, not A. eupatoria. In 110 Japanese adults aged 40 to 59, 50 mg/day of an A. pilosa extract for 8 weeks did not significantly change the primary or secondary immune-cell endpoints versus placebo; the study was funded by the extract's maker, which employs most authors.